Alivio Therapeutics
Alivio Therapeutics is pioneering a new way to treat inflammatory diseases based on precisely tuning the immune system.
Date | Investors | Amount | Round |
---|---|---|---|
$3.3m | Grant | ||
N/A | Acquisition | ||
Total Funding | CAD4.5m |
Related Content
Recent News about Alivio Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.